Capital Impact Advisors, LLC Iovance Biotherapeutics, Inc. Transaction History

Capital Impact Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$16.55 - $27.63 $676,679 - $1.13 Million	-40,887 Closed	0 $0
Q2 2021 Aug 17, 2021	BUY	$16.33 - $33.07 $397,243 - $804,460	24,326 Added 146.89%	40,887 $1.06 Million
Q1 2021 May 18, 2021	SELL	$28.67 - $52.59 $1.82 Million - $3.34 Million	-63,439 Reduced 79.3%	16,561 $524,000
Q3 2020 Nov 13, 2020	BUY	$27.75 - $36.3 $2.22 Million - $2.9 Million	80,000 New	80,000 $2.63 Million

313

237M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.18B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Capital Impact Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Impact Advisors, LLC with notifications on news.